Careplus Group (0163) Fundamentals 2026 — Revenue Analysis | SniperIQ
Careplus Group (0163) is a MY-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of RM59M, trading at RM0.07 on the KLS. This SniperIQ fundamentals page covers Careplus Group's valuation, profitability (net margin -67.6%), revenue (RM99M in FY2024), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Careplus Group's market cap?
Careplus Group (0163) has a market capitalization of approximately RM59M, trading at RM0.07 on the KLS. Market cap moves with the live share price.
What is Careplus Group's P/E ratio?
Careplus Group's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Careplus Group?
Careplus Group runs a net profit margin of -67.6%, a gross margin of -4.1%, and an operating margin of -16.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Careplus Group generate?
Careplus Group reported revenue of RM99M for fiscal year 2024, with net income of -RM82M and earnings per share (EPS) of -0.11. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Careplus Group pay a dividend?
Careplus Group does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Careplus Group financially healthy?
Careplus Group carries a debt-to-equity ratio of 0.17x and a current ratio of 1.14x, with a market beta of -0.06. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Careplus Group a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Careplus Group (0163) the key facts are: market cap RM59M, revenue RM99M, 52-week range 0.06-0.12. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Careplus Group's full fundamentals live
Get Careplus Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.